+/-
If patient at risk for MSSA OR MRSA (see clinical considerations below)
750mg PO q12h OR 400mg IV q8-12h
+/-
If MRSA risk factors (see clinical considerations below)
7-8 days
S. aureus infections: Longer duration required, 14 days
P. aeruginosa infections: Longer duration frequently required, 10-14 days
Suspect if:
OR